Cargando…
晚期肺腺癌患者化疗前后血清EGFR基因突变状态的比较
BACKGROUND AND OBJECTIVE: Non-small cell lung cancer (NSCLC) with mutations in the epidermal growth factor receptor (EGFR) is a distinct subgroup of NSCLC, which is particularly responsive to EGFR tyrosine kinase inhibitors (TKIs). The aim of this study is to detect EGFR mutations in paired serum of...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999769/ https://www.ncbi.nlm.nih.gov/pubmed/21342642 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.02.04 |
Ejemplares similares
-
晚期肺腺癌患者一线治疗前后EGFR基因突变差异性分析
Publicado: (2018) -
ALK基因状态与晚期肺腺癌患者一线培美曲塞化疗疗效的关系
Publicado: (2017) -
晚期NSCLC患者血清EGFR基因突变状态的测定及意义
Publicado: (2013) -
HER2基因状态与晚期肺腺癌患者一线培美曲塞联合铂类化疗疗效的关系
Publicado: (2019) -
肺腺癌EGFR与KRAS基因突变状态分析
Publicado: (2015)